Skip to main content

COMBI-AD: how does it change melanoma patient management?

By 14 Dicembre 2017Aprile 7th, 2021No Comments
Dai congressi

We met Paolo Ascierto (Direttore della Struttura Complessa di Oncologia Medica e Terapie Innovative dell’Istituto Nazionale Tumori Fondazione “G. Pascale”) during the Symposium: “Bridge from adjuvant to metastatic melanoma: treating your BRAF+ patients with target therapy”, held at the Melanoma BRIDGE congress 2017, in Naples.